Werewolf Therapeutics provided a business update, announcing progress in their clinical trials for WTX-124, a conditionally activated therapeutic for cutaneous melanoma, with full enrollment in ...
Hosted on MSN10mon
200 Years Before The Salem Witch Trials, There Were Werewolf Trials Held In EuropeThe Salem witch trials of 1692 have gone down in history as one of the most infamous events to ever occur in America. But 200 years prior, in Europe, people were being accused of lycanthropy or ...
Reports Q4 revenue $0 vs. $301,590. “Werewolf made considerable progress in 2024 with promising preliminary evidence of durable anti-tumor ...
- Full enrollment in cutaneous melanoma dose-expansion arms of Phase 1/1b clinical trial evaluating WTX-124 as monotherapy ...
The Metropolitan Museum of Art, New York "The Werewolf or the Cannibal" Akin to the infamous witch trials that swept through Europe and later the United States, a number of European countries dealt ...
Full enrollment in cutaneous melanoma dose-expansion arms of Phase 1/1b clinical trial evaluating WTX-124 as monotherapy and in combination with pembrolizumab expected by the end of the first half ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback